Addressing and managing comorbidities

23 May 2023

By IFPA

IFPA Forum 2023 Asia

Optimal treatment of psoriatic disease and its comorbidities requires shifting to a people-centered, multidisciplinary, and health service model. Person-centered care is essential to improve the quality of life for people living with psoriatic disease.

ifpa-pso.com/global-actions/forum

Related content

tool Advocacy, Toolkits

Design it right: A checklist for diverse, equitable, patient-first trials

tool Advocacy, Toolkits

Glossary: Common terms in clinical research

tool Advocacy, Toolkits

Before you join a study: A practical guide for participation in clinical trials

tool Advocacy, Toolkits

Breaking The Myths: Clinical trials and psoriatic disease

Combined Shape